DOCSLIB.ORG

List of Hk Marginable Securities

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Hk Marginable Securities LIST OF HK MARGINABLE SECURITIES TICKER COUNTER NAME TICKER COUNTER NAME TICKER COUNTER NAME 1530 3SBIO INC 2018 AAC TECHNOLOGIES 241 ALIBABA HEALTH 1045 APT SATELLITE HL 1288 ABC-H 3319 A-LIVING SMART C 1672 ASCLETIS PHARMA 900 AEON CREDIT SERV 373 ALLIED GROUP LTD 662 ASIA FINAN HLDGS 3383 AGILE GROUP HOLD 9966 ALPHAMAB ONCOLOG 1675 ASIAINFO TECHNOL 1299 AIA 2600 ALUMINUM CORP-H 522 ASM PACIFIC 753 AIR CHINA LTD-H 347 ANGANG STEEL-H 1717 AUSNUTRIA 1789 AK MEDICAL HOLDI 995 ANHUI EXPRESS-H 2357 AVICHINA INDUS-H 9988 ALIBABA GROUP HO 2020 ANTA SPORTS PROD 1958 BAIC MOTOR-H 3328 BANKCOMM-H 371 BJ ENT WATER 9888 BAIDU INC-A 2355 BAOYE GROUP CO-H 2588 BOC AVIATION LTD 874 BAIYUNSHAN PH-H 2009 BBMG CORP-H 2388 BOC HONG KONG HO 23 BANK EAST ASIA 6160 BEIGENE LTD 3329 BOCOM INTERNATIO 3988 BANK OF CHINA-H 694 BEIJING CAP AI-H 710 BOE VARITRONIX L 1963 BANK OF CHONGQ-H 1599 BEIJING URBAN-H 3998 BOSIDENG INTL 6199 BANK OF GUIZHO-H 2111 BEST PACIFIC INT 1428 BRIGHT SMART 3866 BANK OF QINGD-H 3358 BESTWAY GLOBAL H 1876 BUDWEISER BREWIN 6196 BANK OF ZHENGZ-H 392 BJ ENT HLDGS 1211 BYD CO LTD-H 1224 C C LAND HOLDING 1898 CHINA COAL ENE-H 1763 CHINA ISOTOPE & 1908 C&D INTERNATIONA 1800 CHINA COM CONS-H 817 CHINA JINMAO HOL 341 CAFE DE CORAL 552 CHINA COMM SER-H 1890 CHINA KEPEI EDUC 1848 CALC 1387 CHINA DILI GROUP 2128 CHINA LESSO 6185 CANSINO BIOLOG-H 670 CHINA EAST AIR-H 2628 CHINA LIFE-H 1381 CANVEST ENV 667 CHINA EAST EDUCA 1234 CHINA LILANG LTD 293 CATHAY PAC AIR 839 CHINA EDUCATION 772 CHINA LITERATURE 939 CCB-H 165 CHINA EVER LTD 1589 CHINA LOGISTICS 6818 CEB BANK-H 1257 CHINA EVERBRIGHT 916 CHINA LONGYUAN-H 832 CENTRAL CHINA 257 CHINA EVERBRIGHT 867 CHINA MEDICAL SY 1816 CGN POWER-H 3333 CHINA EVERGRAND 1268 CHINA MEIDONG AU 6881 CGS-H 6186 CHINA FEIHE LTD 6099 CHINA MERCHAN-H 2778 CHAMPION REIT 506 CHINA FOODS LTD 144 CHINA MERCHANTS 951 CHAOWEI POWER 384 CHINA GAS HOLDIN 1503 CHINA MERCHANTS 25 CHEVALIER INTL 512 CHINA GRAND PHAR 1988 CHINA MINSHENG-H 3883 CHINA AOYUAN GRO 3836 CHINA HARMONY AU 941 CHINA MOBILE 3983 CHINA BLUECHEM-H 658 CHINA HIGH-SPEED 1117 CHINA MODERN DAI 1359 CHINA CINDA-H 3908 CHINA INTERNAT-H 26 CHINA MOTOR BUS Note: - All HK shares are subject to a maximum cap equivalent to S$300,000 per counter. Financing available is calculated at 80% of valuation. All types of warrants are not marginable. The above list is subject to change at the discretion of the management without prior notice. wef 30 April 2021 Page 1 of 6 LIST OF HK MARGINABLE SECURITIES TICKER COUNTER NAME TICKER COUNTER NAME TICKER COUNTER NAME 3323 CHINA NATL BDG-H 966 CHINA TAIPING IN 1038 CKI HOLDINGS 2001 CHINA NEW HIGHER 728 CHINA TELECOM-H 2 CLP HOLDINGS 1258 CHINA NONFERROUS 1252 CHINA TIANRUI GR 3968 CM BANK-H 2883 CHINA OILFIELD-H 762 CHINA UNICOM 302 CMGE TECHNOLOGY 581 CHINA ORIENTAL 2202 CHINA VANKE-H 3993 CMOC-H 688 CHINA OVERSEAS 6166 CHINA VAST INDUS 883 CNOOC 81 CHINA OVERSEAS G 855 CHINA WATER AFFA 1610 COFCO JOYCOME FO 2669 CHINA OVERSEAS P 2779 CHINA XINHUA EDU 400 COGOBUY GROUP 2601 CHINA PACIFIC-H 1866 CHINA XLX FERTIL 1778 COLOUR LIFE SERV 2380 CHINA POWER INTE 3669 CHINA YONGDA AUT 2342 COMBA TELECOM SY 1186 CHINA RAIL CN-H 6169 CHINA YUHUA EDUC 914 CONCH CEMENT-H 390 CHINA RAIL GR-H 2016 CHINA ZHESHANG-H 586 CONCH VENTURE 3969 CHINA RAILWAY -H 1333 CHINA ZHONGWANG 1681 CONSUN PHARMACEU 1911 CHINA RENAISSANC 354 CHINASOFT INTL 1138 COSCO SHIP ENG-H 1313 CHINA RES CEMENT 127 CHINESE ESTATES 1919 COSCO SHIP HOL-H 1193 CHINA RES GAS 1111 CHONG HING BANK 517 COSCO SHIPPING I 1109 CHINA RES LAND 116 CHOW SANG SANG 1199 COSCO SHIPPING P 836 CHINA RES POWER 1929 CHOW TAI FOOK JE 2007 COUNTRY GARDEN 1515 CHINA RESOURCES 884 CIFI HOLDINGS GR 6098 COUNTRY GARDEN S 291 CHINA RESOURCES 3899 CIMC ENRIC HLDG 1415 COWELL 3320 CHINA RESOURCES 1839 CIMC VEHICLES -H 906 CPMC HOLDINGS 1907 CHINA RISUN GROU 2039 CIMC-H 3618 CQRC BANK-H 2198 CHINA SANJIANG F 267 CITIC 32 CROSS-HAR HLDGS 1966 CHINA SCE GROUP 998 CITIC BANK-H 1766 CRRC CORP LTD -H 691 CHINA SHANSHUI 6030 CITIC SEC-H 2232 CRYSTAL INTERNAT 1088 CHINA SHENHUA-H 1883 CITIC TELECOM 6066 CSC FINANCIAL-H 2877 CHINA SHINEWAY 256 CITYCHAMP 1093 CSPC PHARMACEUTI 1055 CHINA SOUTHERN-H 1113 CK ASSET HOLDING 317 CSSC OFFSHORE -H 3311 CHINA STATE CONS 1 CKH HOLDINGS 2616 CSTONE PHARMACEU 956 CHINA SUNTIEN-H 1090 DA MING INTERNAT 3958 DFZQ-H 1126 DREAM INTL LTD 6111 DAFA PROPERTIES 861 DIGITAL CHINA 1330 DYNAGREEN ENVI-H 440 DAH SING 1072 DONGFANG ELECT-H 6889 DYNAM JAPAN 2356 DAHSING BANKING 489 DONGFENG MOTOR-H 29 DYNAMIC HLDG. 3799 DALI FOODS GROUP 895 DONGJIANG ENV-H 2019 DEXIN CHINA HOLD 189 DONGYUE GROUP Note: - All HK shares are subject to a maximum cap equivalent to S$300,000 per counter. Financing available is calculated at 80% of valuation. All types of warrants are not marginable. The above list is subject to change at the discretion of the management without prior notice. wef 30 April 2021 Page 2 of 6 LIST OF HK MARGINABLE SECURITIES TICKER COUNTER NAME TICKER COUNTER NAME TICKER COUNTER NAME 382 EDVANTAGE GROUP 2688 ENN ENERGY 1995 EVER SUNSHINE LI 3709 EEKA FASHION HOL 1821 ESR CAYMAN LTD 6178 EVERBRIGHT SEC-H 2048 E-HOUSE CHINA EN 3360 FAR EAST HORIZON 6088 FIT HON TENG LTD 6820 FRIENDTIMES INC 6288 FAST RETAIL-HDR 778 FORTUNE REIT 1521 FRONTAGE HOLDING 35 FE CONSORT INTL 656 FOSUN INTL 1448 FU SHOU YUAN INT 142 FIRST PACIFIC 2196 FOSUN PHARMA-H 546 FUFENG GROUP LTD 38 FIRST TRACTOR-H 1992 FOSUN TOURISM GR 3606 FUYAO GLASS IN-H 27 GALAXY ENTERTAIN 1271 GRAND MING 270 GUANGDONG INVEST 175 GEELY AUTOMOBILE 41 GREAT EAGLE 2238 GUANGZHOU AUTO-H 2666 GENERTEC UNIVERS 468 GREATVIEW ASEPTI 2777 GUANGZHOU R&F -H 1548 GENSCRIPT BIOTEC 337 GREENLAND HONG K 53 GUOCO GROUP LTD 1776 GF SECURITIES-H 3900 GREENTOWN CHINA 1456 GUOLIAN SECURI-H 3308 GOLDEN EAGLE RET 2869 GREENTOWN SERVIC 2611 GUOTAI JUNAN S-H 533 GOLDLION HLDG 6862 HAIDILAO INTERNA 1044 HENGAN INTL 5 HSBC HOLDINGS PL 1882 HAITIAN INTL 921 HISENSE HOME - H 1347 HUA HONG SEMI 665 HAITONG INT'L 2638 HK ELECTRIC INVE 336 HUABAO INTL 6837 HAITONG SECURI-H 45 HK&S HOTELS 1071 HUADIAN POWER-H 10 HANG LUNG GROUP 1310 HKBN LTD 1756 HUALI UNIVERSITY 101 HANG LUNG PPT 388 HKEX 902 HUANENG POWER-H 11 HANG SENG BANK 480 HKR INTL LTD 6886 HUATAI SECURIT-H 3692 HANSOH PHARMACEU 6823 HKT-SS 87001 HUI XIAN REIT 1112 HEALTH AND HAPPI 3 HONG KG CHINA GS 9968 HUIJING HOLDINGS 1596 HEBEI YICHEN I-H 50 HONG KG FERR 3698 HUISHANG BANK-H 6885 HENAN JINMA EN-H 1137 HONG KONG TELEVI 14 HYSAN DEV 12 HENDERSON LAND D 1765 HOPE EDUCATION G 1398 ICBC-H 1970 IMAX CHINA HOLDI 9969 INNOCARE PHARMA 1119 IDREAMSKY TECHNO 1286 IMPRO PRECISION 1801 INNOVENT BIOLOGI 799 IGG INC 3700 INKE LTD 1931 IVD MEDICAL HOLD Note: - All HK shares are subject to a maximum cap equivalent to S$300,000 per counter. Financing available is calculated at 80% of valuation. All types of warrants are not marginable. The above list is subject to change at the discretion of the management without prior notice. wef 30 April 2021 Page 3 of 6 LIST OF HK MARGINABLE SECURITIES TICKER COUNTER NAME TICKER COUNTER NAME TICKER COUNTER NAME 9618 JD.COM INC-CL A 2768 JIAYUAN INTERNAT 579 JNCEC-H 1935 JH EDUCATIONAL T 6122 JILIN JIUTAI R-H 179 JOHNSON ELEC H 177 JIANGSU EXPRES-H 1862 JINGRUI HOLDINGS 3336 JU TENG INTL HDG 1916 JIANGXI BANK-H 1951 JINXIN FERTILITY 2231 JY GRANDMARK HOL 358 JIANGXI COPPER-H 3306 JNBY DESIGN LTD 173 K WAH INTL HLDGS 683 KERRY PPT 34 KOWLOON DVLP CO 1638 KAISA GROUP 148 KINGBOARD HOLDIN 135 KUNLUN ENERGY 1888 KB LAMINATES 268 KINGDEE INTL SFT 3768 KUNMING DIANCH-H 636 KERRY LOGISTICS 3888 KINGSOFT CORP 1813 KWG GROUP HOLDIN 746 L & M CHEMICAL 2331 LI NING CO LTD 960 LONGFOR GROUP HO 488 LAI SUN DEV 1212 LIFESTYLE INTL 3339 LONKING 191 LAI SUN GARMENT 823 LINK REIT 590 LUK FOOK HLDGS I 2314 LEE & MAN PAPER 194 LIU CHONG INV 255 LUNG KEE HLDG 950 LEE'S PHARM 1513 LIVZON PHARM-H 2186 LUYE PHARMA GROU 3396 LEGEND HOLDING-H 973 L'OCCITANE INTL 95 LVGEM CHINA REAL 992 LENOVO GROUP 3380 LOGAN GROUP CO L 323 MAANSHAN IRON-H 2319 MENGNIU DAIRY 425 MINTH GROUP LTD 945 MANULIFE FIN 1618 METALLURGICAL-H 71 MIRAMAR HOT &INV 1896 MAOYAN ENTERTAIN 2282 MGM CHINA 1860 MOBVISTA INC 1317 MAPLELEAF EDU 853 MICROPORT SCIENT 3600 MODERN DENTAL GR 3690 MEITUAN-B 3990 MIDEA REAL ESTAT 66 MTR CORP 200 MELCO INTL DEV 222 MIN XIN HLDGS 3918 NAGACORP LTD 1336 NEW CHINA LIFE-H 2689 NINE DRAGONS PAP 553 NANJING PANDA-H 17 NEW WORLD DEV 1475 NISSIN FOODS CO 777 NETDRAGON WEBSOF 1316 NEXTEER 659 NWS HOLDINGS 1275 NEW CENTURY REIT 316 ORIENT OVERSEAS Note: - All HK shares are subject to a maximum cap equivalent to S$300,000 per counter.
Load more

Recommended publications
  • SUNAC CHINA HOLDINGS LIMITED 融創中國控股有限公司 (Incorporated in the Cayman Islands with Limited Liability) (Stock Code: 01918)
    THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt about any aspect of this circular or as to the action to be taken, you should consult your licensed securities dealer or registered institution in securities, bank manager, solicitor, professional accountant or other professional advisers. If you have sold or transferred all your shares in Sunac China Holdings Limited, you should at once hand this circular together with the enclosed form of proxy to the purchaser(s) or transferee(s) or to the bank, licensed securities dealer or registered institution in securities or other agent through whom the sale or transfer was effected for transmission to the purchaser(s) or transferee(s). Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this circular, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this circular. This circular appears for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for any securities. SUNAC CHINA HOLDINGS LIMITED 融創中國控股有限公司 (incorporated in the Cayman Islands with limited liability) (Stock Code: 01918) (1) CONNECTED TRANSACTION — PROPOSED SHARE ISSUANCE UNDER SPECIFIC MANDATE AND (2) APPLICATION FOR WHITEWASH WAIVER Independent Financial Adviser to the Independent Board Committee and the Independent Shareholders Capitalised terms used on this cover shall have the same meanings as those defined in the section headed “Definition” in this circular, unless the context requires otherwise.
    [Show full text]
  • Three Red Lines” Policy
    Real Estate Developers with High Leverage to See Inventory Quality Tested Under Broader “Three Red Lines” Policy October 28, 2020 In our view, the widening of regulations aimed at controlling real estate developers’ interest- ANALYSTS bearing debt would further reduce the industry’s overall credit risk in the long term. However, the nearer term may see less headroom for highly leveraged developers to finance in the capital Xiaoliang Liu, CFA market, pushing them to sell off inventory to ease liquidity pressure. Beijing +86-10-6516-6040 The People’s Bank of China said in September that measures aimed at monitoring the funding [email protected] and financial management of key real estate developers will steadily be expanded. Media reports suggest that the new regulations would see a cap of 15% on annual growth of interest-bearing Jin Wang debt for all property developers. Developers will be assessed against three indicators, which are Beijing called “red lines”: whether asset liability ratios (excluding advance) exceeded 70%; whether net +86-10-6516-6034 gearing ratio exceeded 100%; whether cash to short-term debt ratios went below 1.0. Developers [email protected] which breached all three red lines won’t be allowed to increase their debt. If only one or two of the red lines are breached, such developers would have their interest-bearing debt growth capped at 5% and 10% respectively. The first half of the year saw debt grow rapidly among developers. In a sample of 87 real estate developers that we are monitoring, more than 40% saw their interest-bearing debt grow at a faster rate than 15% year over year as of the end of June (see the chart below).
    [Show full text]
  • Placing 400 Million New Shares at HKD 25.25, Underlying Profit
    Company Report: CR Land (01109 HK) Van Liu 刘斐凡 公司报告：华润置地 (01109 HK) +86 755 23976672 [email protected] 国泰君安研究 25 May 2015 Placing 400 million New Shares at HKD 25.25, Underlying Profit Revised up, Maintain fiBuyfl Research GTJA 以25.25港元配售4亿股,调高核心净利，维持“买入” Rating: Buy Maintained z CR Land (fithe Companyfl) plans to raise approximately HK$ 10.1 billion 评级： 买入 维持 by placing 400 million new shares at a price of HK$ 25.25 per placing ( ) share. The management intends to use the raised capital for further land acquisition, development costs and general working capital purposes. 6-18m TP 目标价: HK$29.40 Revised from 原目标价: HK$28.70 z Limited diluted effects with stronger balance sheet. As per our estimates, after the share placing completion, the underlying EPS will increase 0.3% due Share price 股价： HK$25.300 to the underlying profit being revised up and net gearing ratio will decrease 13.0 ppts in 2015E. Stock performance z Raised capital from share placing will help the Company’s land 股价表现 replenishment and new house set up plan acceleration, which is able to translate into earnings growth under the rebounding sales environment. 100.0 % of return z Maintain ‘Buy’. Raised capital from share pricing will help sales increase. 80.0 Expectations of loosening policies and southbound capital inflow with housing 60.0 sales rebound in April 2015 are likely to drive property companies’ valuation upside potential. We revise up the target price to HK$29.40, which represents 40.0 an 15% discount to revised 2015E NAV per share, 12.3x 2015 underlying 20.0 PER and 1.6x 2015 PBR.
    [Show full text]
  • STOXX Hong Kong All Shares 180 Last Updated: 01.05.2015
    STOXX Hong Kong All Shares 180 Last Updated: 01.05.2015 Rank Rank (PREVIOUS ISIN Sedol RIC Int.Key Company Name Country Currency Component FF Mcap (BEUR) (FINAL) ) KYG875721634 BMMV2K8 0700.HK B01CT3 Tencent Holdings Ltd. CN HKD Y 97.0 1 1 HK0000069689 B4TX8S1 1299.HK HK1013 AIA GROUP HK HKD Y 71.8 2 2 CNE1000002H1 B0LMTQ3 0939.HK CN0010 CHINA CONSTRUCTION BANK CORP H CN HKD Y 69.5 3 4 HK0941009539 6073556 0941.HK 607355 China Mobile Ltd. CN HKD Y 67.4 4 3 CNE1000003G1 B1G1QD8 1398.HK CN0021 ICBC H CN HKD Y 59.3 5 5 CNE1000001Z5 B154564 3988.HK CN0032 BANK OF CHINA 'H' CN HKD Y 46.7 6 6 HK0388045442 6267359 0388.HK 626735 Hong Kong Exchanges & Clearing HK HKD Y 37.7 7 10 CNE1000002L3 6718976 2628.HK CN0043 China Life Insurance Co 'H' CN HKD Y 32.3 8 7 CNE1000003X6 B01FLR7 2318.HK CN0076 PING AN INSUR GP CO. OF CN 'H' CN HKD Y 28.9 9 9 HK0013000119 6448068 0013.HK 644806 Hutchison Whampoa Ltd. HK HKD Y 26.7 10 8 KYG217651051 BW9P816 0001.HK 619027 CK HUTCHISON HOLDINGS HK HKD Y 25.5 11 11 CNE1000003W8 6226576 0857.HK CN0065 PetroChina Co Ltd 'H' CN HKD Y 24.2 12 12 HK0883013259 B00G0S5 0883.HK 617994 CNOOC Ltd. CN HKD Y 24.0 13 13 HK0016000132 6859927 0016.HK 685992 Sun Hung Kai Properties Ltd. HK HKD Y 21.6 14 14 CNE1000002Q2 6291819 0386.HK CN0098 China Petroleum & Chemical 'H' CN HKD Y 21.3 15 16 CNE100000205 B0B8Z29 3328.HK CN0054 Bank of Communications Co 'H' CN HKD Y 20.2 16 17 HK0004000045 6435576 0004.HK 643557 Wharf (Holdings) Ltd.
    [Show full text]
  • Annual Report
    2020 (Incorporated in Hong Kong with limited liability) (Stock Code : 00656) Annual Report Profit Attributable to Owners of the Parent RMB 8,017.9 million Innovation & Win The year 2020 might be the most challenging year for Fosun, yet it was also the best year. After the pandemic, we continue with the “wartime mechanism” and maintain the fighting spirit that we have developed during the global combat against COVID-19. This has resulted in our resilient business performance throughout the year. The pandemic has also allowed us to refine further our capabilities of the Company accumulated over the years for “Industry Operations + Industrial Investment”, FC2M model, globalization and technology innovation. Fosun has thus evolved and become even stronger. The theme of Fosun’s annual report this year is “Innovation & Win”. “Innovation” means Fosun always attaches great importance to innovation. We recognize that we can create world-class products only by increasing investment in innovation and R&D. It is also because of our investment in technology innovation in various industries over the years, as well as leveraging on Fosun’s diversified and globalized business portfolio, the development model of “Industry Operations + Industrial Investment”, and the “wartime” mode that it has upkept since the battle against the pandemic, that together effectively defended the impact brought by the external environment and brought the Group a resilient performance, thereby creating mutually beneficial and win-win situation to all stakeholders. The year 2021 is a new starting point for Fosun’s transformation. Facing the huge opportunities in the industrial internet era, we will continue to create good products and put the operation of customers (C-end) as our top priority to fully unlock the multiplier growth of good products and customer resources in Fosun’s ecosystem.
    [Show full text]
  • Biontech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine
    BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine January 25, 2021 COMIRNATY® (also known as BNT162b2, Chinese product name: 復必泰TM) is the first COVID-19 vaccine to receive Authorization for Emergency Use in Hong Kong MAINZ, GERMANY, and SHANGHAI, CHINA, January 25, 2021 —BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or “Group”; Stock Code: 600196.SH, 02196.HK) today announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region of the PRC (“Hong Kong”), the COVID-19 vaccine COMIRNATY® (also known as BNT162b2, Chinese product name: 復必泰TM) based on BioNTech’s proprietary mRNA technology has received authorization for emergency use in Hong Kong. The vaccine will be produced in BioNTech’s manufacturing facilities in Germany and supplied to Hong Kong for administration under the Hong Kong SAR Government’s COVID-19 Vaccination Program. “We are excited and encouraged that COMIRNATY® has been authorized to emergency use in Hong Kong. This is an important milestone in the joint efforts of BioNTech and Fosun Pharma to achieve vaccine accessibility globally. We will continue working closely with BioNTech to complete the ongoing clinical trial and marketing registration in Greater China,” Wu Yifang, Chairman and CEO of Fosun Pharma said. “We will also cooperate closely with HKSAR regarding vaccination deployment plan to ensure that Hong Kong citizens can receive a well-tolerated and effective mRNA COVID-19 vaccine as soon as possible in order to protect the health of millions of households.” On 16 March 2020, BioNTech and Fosun Pharma announced a strategic collaboration to work jointly on the development and commercialization of a COVID-19 vaccine product in Greater China based on BioNTech’s proprietary mRNA technology platform.
    [Show full text]
  • Gemdale Properties and Investment Corporation Limited 金地商置集團有限公司* (Incorporated in Bermuda with Limited Liability) (Stock Code: 535)
    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Gemdale Properties and Investment Corporation Limited * 金地商置集團有限公司 (Incorporated in Bermuda with limited liability) (Stock Code: 535) DISCLOSEABLE TRANSACTION DISPOSAL OF 74% OF A SUBSIDIARY DISPOSAL OF 74% OF A SUBSIDIARY The Board announces that, on 12 July 2018, One Polaris, Shenzhen Weixin, Fainmark and Nanjing Jiqingfeng (all of which are indirect wholly-owned subsidiaries of the Company, as the Vendors) and Perfect Area, Shanghai Hongxing, Xuzhou Vanke and Charm Silver (collectively, as the Purchasers) entered into the Agreement in relation to the Disposal. Upon completion of the Disposal, the Group’s effective equity interest in the Target Company will be reduced from 100% to 26% and the Target Company will be under the joint control of the parties to the Agreement. Therefore, the Target Company will cease to be accounted for as a subsidiary of the Company and will be accounted for as a joint venture of the Group. The financial results of the Target Company will no longer be consolidated into the consolidated financial statements of the Group. LISTING RULES IMPLICATIONS As one the applicable percentage ratios (as defined under the Listing Rules) exceed 5% but are less than 25%, the entering into of the Agreement and the transactions contemplated thereunder (including the consideration) constitutes a discloseable transaction of the Company and is subject to the reporting and announcement requirements under Chapter 14 of the Listing Rules.
    [Show full text]
  • China Reits Property Landlords to Shine 19
    SECTOR BRIEFING number DBS Asian Insights DBS Group59 Research • May 2018 China REITs Property Landlords to Shine 19 DBS Asian Insights SECTOR BRIEFING 59 02 China REITs Property Landlords to Shine Ken HE Equity Analyst DBS (Hong Kong) [email protected] Carol WU Head of Greater China Research DBS (Hong Kong) [email protected] Danielle WANG CFA Equity Analyst DBS (Hong Kong) [email protected] Derek TAN Equity Analyst DBS Group Research [email protected] Jason LAM Equity Analyst DBS (Hong Kong) [email protected] Produced by: Asian Insights Office • DBS Group Research go.dbs.com/research @dbsinsights [email protected] Goh Chien Yen Editor-in-Chief Jean Chua Managing Editor Martin Tacchi Art Director 19 DBS Asian Insights SECTOR BRIEFING 59 03 04 Executive Summary 08 China REITs Are Lagging Edging Towards Onshore REITs Major Obstacles in Fostering 18 an Onshore REIT Regime CMBS/CMBNs Are Growing Faster C-REITs Are Imminent Which Asset Type Will Benefit 28 More? Modern Logistics Properties The Rise of Active Property Asset Management Which Developer Will Benefit From the Establishment of C-REITs? 49 Appendix DBS Asian Insights SECTOR BRIEFING 59 04 Executive Summary No REIT regime yet he real estate investment trust (REIT) has become an important investment vehicle as evidenced by its separation from the financial sector in the Global Industry Classification Standard as a sector on its own. Major Asian countries/regions have joined western countries to kickstart local versions of REITs, leaving China the last Tbig economy that has yet to have such an investment vehicle. Two major technical In our view, removing legislative obstacles (publicly traded funds are not allowed to obstacles hold commercial properties) is the first step that the government needs to take towards establishing a modern REIT regime.
    [Show full text]
  • ACAL China Equity Nov17
    ARETE CAPITAL ASIA CHINA: VALUE IN SELECTED NAMES CHINA EQUITY – OVERVIEW CHINA IS TAKING ITS PLACE ON THE WORLD STAGE • China is a critical player in the world economy and is the worlds largest economy on a purchasing power parity basis. • Xi’s position has been reinforced for the next 5yrs and possibly beyond. The new leadership will retain existing key policies with a focus on economic reform and an emphasis on foreign policy. ECONOMIC TRANSFORMATION WELL UNDERWAY • ‘Smokestack’ industries (coal, aluminium and steel) and ‘providing for populace’ businesses (consumer staples and healthcare) are no longer so dominant and being overtaken by manufacturers and service companies. • In many cases, these new ‘service’ industries are redefining business models in established sectors • The China government has selected and carefully encouraged special policies/industries to have Chinese operations challenge the established order – internally and externally INVESTMENT OPPORTUNITIES EXIST • Amongst the many transformations taking place in China, there are numerous great investment opportunities. We do not recommend an index, but selected stocks • Some of these stocks have made significant gains over the last 12months, but there is still more to come 2 CONTENT OVERVIEW ECONOMY Economy Issues Diversification 4 5 6 Equities Remninbi VALUATIONS 7 8 SITUATIONS MiddlePORTFOLIO Class ecosystem ADVISORY 9 10 SELECTED STOCKS Preferred 11 Valuations 13 3 CHINA – ECONOMY CHINA’s ECONOMIC GROWTH REMAINS RESILIENT … • IMF forecasts (not a leading indicator)
    [Show full text]
  • U.S. Investors Are Funding Malign PRC Companies on Major Indices
    U.S. DEPARTMENT OF STATE Office of the Spokesperson For Immediate Release FACT SHEET December 8, 2020 U.S. Investors Are Funding Malign PRC Companies on Major Indices “Under Xi Jinping, the CCP has prioritized something called ‘military-civil fusion.’ … Chinese companies and researchers must… under penalty of law – share technology with the Chinese military. The goal is to ensure that the People’s Liberation Army has military dominance. And the PLA’s core mission is to sustain the Chinese Communist Party’s grip on power.” – Secretary of State Michael R. Pompeo, January 13, 2020 The Chinese Communist Party’s (CCP) threat to American national security extends into our financial markets and impacts American investors. Many major stock and bond indices developed by index providers like MSCI and FTSE include malign People’s Republic of China (PRC) companies that are listed on the Department of Commerce’s Entity List and/or the Department of Defense’s List of “Communist Chinese military companies” (CCMCs). The money flowing into these index funds – often passively, from U.S. retail investors – supports Chinese companies involved in both civilian and military production. Some of these companies produce technologies for the surveillance of civilians and repression of human rights, as is the case with Uyghurs and other Muslim minority groups in Xinjiang, China, as well as in other repressive regimes, such as Iran and Venezuela. As of December 2020, at least 24 of the 35 parent-level CCMCs had affiliates’ securities included on a major securities index. This includes at least 71 distinct affiliate-level securities issuers.
    [Show full text]
  • Hang Seng Indexes Announces Index Review Results
    14 August 2020 Hang Seng Indexes Announces Index Review Results Hang Seng Indexes Company Limited (“Hang Seng Indexes”) today announced the results of its review of the Hang Seng Family of Indexes for the quarter ended 30 June 2020. All changes will take effect on 7 September 2020 (Monday). 1. Hang Seng Index The following constituent changes will be made to the Hang Seng Index. The total number of constituents remains unchanged at 50. Inclusion: Code Company 1810 Xiaomi Corporation - W 2269 WuXi Biologics (Cayman) Inc. 9988 Alibaba Group Holding Ltd. - SW Removal: Code Company 83 Sino Land Co. Ltd. 151 Want Want China Holdings Ltd. 1088 China Shenhua Energy Co. Ltd. - H Shares The list of constituents is provided in Appendix 1. The Hang Seng Index Advisory Committee today reviewed the fast expanding innovation and new economy sectors in the Hong Kong capital market and agreed with the proposal from Hang Seng Indexes to conduct a comprehensive study on the composition of the Hang Seng Index. This holistic review will encompass various aspects including, but not limited to, composition and selection of constituents, number of constituents, weightings, and industry and geographical representation, etc. The underlying aim of the study is to ensure the Hang Seng Index continues to serve as the most representative and important benchmark of the Hong Kong stock market. Hang Seng Indexes will report its findings and propose recommendations to the Advisory Committee within six months. The number of constituents of the Hang Seng Index may increase during this period. Hang Seng Indexes Announces Index Review Results /2 2.
    [Show full text]
  • China Jinmao (817 HK) China Jinmao
    China Financials 26 July 2016 China Jinmao (817 HK) China Jinmao Target price: HKD2.97 Share price (25 Jul): HKD2.26 | Up/downside: +31.4% Initiation: access to prime assets Cynthia Chan (852) 2773 8243 One of the few to have exposure to primary development in tier-2 cities [email protected] A proven brand in high-end housing; growing rentals in tier-1 cities Jonas Kan, CFA (852) 2848 4439 [email protected] Initiating with Buy (1) rating and 12-month target price of HKD2.97 Investment case: We initiate coverage of China Jinmao, the real estate Share price performance flagship of stated-owned Sinochem Corporation, with a Buy (1) call. We (HKD) (%) see China Jinmao as one of the few China developers with a differentiated 2.7 120 2.5 110 and sustainable business model, proven expertise in the primary land 2.2 100 development business in major tier-2 cities (Nanjing and Changsha), and a 2.0 90 sound reputation for high-end residential projects in upper-tier cities 1.7 80 (especially Beijing and Shanghai). Moreover, earnings should be backed by Jul-15 Oct-15 Jan-16 Apr-16 solid and growing recurrent income from several prime rental properties Franshion (LHS) Relative to HSI (RHS) and hotels, many of which are located in core areas of tier-1 cities. 12-month range 1.74-2.66 We believe China Jinmao’s primary development business differentiates it Market cap (USDbn) 3.10 3m avg daily turnover (USDm) 1.49 from other developers, especially at a time when property development Shares outstanding (m) 10,672 margins are shrinking and profitability is becoming harder to maintain.
    [Show full text]